We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Efficacy of Talampanel in Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00267592
Recruitment Status : Completed
First Posted : December 21, 2005
Last Update Posted : May 19, 2016
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2008
  Study Completion Date : February 2011
  Certification or Request for Extension to Delay Results Submission: August 16, 2011